摘要 |
The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, esters, or prodrugs thereof: (structurally represented), which inhibit RNA-containing virus, particularly the hepatitis C virus (HCV). Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. |
申请人 |
ENANTA PHARMACEUTICALS, INC.;NOVARTIS AG |
发明人 |
QIU, YAO-LING;CAO, HUI;PENG, XIAOWEN;GAO, XURI;OR, YAT, SUN;SWEENEY, ZACHARY, KEVIN |